Literature DB >> 13932245

In-vitro and in-vivo studies of a preparation of urokinase.

G P MCNICOL, S B GALE, A S DOUGLAS.   

Abstract

Keywords:  BLOOD COAGULATION TESTS; STREPTODORNASE AND STREPTOKINASE

Mesh：

Substances：

Year:  1963        PMID： 13932245      PMCID： PMC2122826          DOI： 10.1136/bmj.1.5335.909

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  24 in total

1.  Experience with streptokinase infusions.

Authors:  G P MCNICOL; A S DOUGLAS; C BAYLEY
Journal:  Lancet       Date:  1962-12-22       Impact factor: 79.321

2.  Blood clotting activities of thrombolytic agents with special reference to a Hageman-like effect.

Authors:  S G IATRIDIS; E G WILSON; J H FERGUSON; H A RIERSON
Journal:  Thromb Diath Haemorrh       Date:  1960-10-01

3.  Studies on enhanced fibrinolytic activity in man.

Authors:  S SHERRY; R I LINDEMEYER; A P FLETCHER; N ALKJAERSIG
Journal:  J Clin Invest       Date:  1959-05       Impact factor: 14.808

4.  The preparation and use of 131 I-tagged fibrinogen to demonstrate fibrinolysis.

Authors:  W E CLEMENT; G P McNICOL
Journal:  J Clin Pathol       Date:  1959-11       Impact factor: 3.411

5.  Clotting deviations in man during cardiac bypass: fibrinolysis and circulating anticoagulant.

Authors:  K N VON KAULLA; H SWAN
Journal:  J Thorac Surg       Date:  1958-10

6.  Urokinase an activator of plasminogen from human urine. I. Isolation and properties.

Authors:  J PLOUG; N O KJELDGAARD
Journal:  Biochim Biophys Acta       Date:  1957-05

7.  Partial purification and properties of a proteolytic enzyme of human serum.

Authors:  L F REMMERT; P P COHEN
Journal:  J Biol Chem       Date:  1949-11       Impact factor: 5.157

8.  Studies of the plasmin system. III. Physical properties of the two plasmin inhibitors in plasma.

Authors:  P S NORMAN; B M HILL
Journal:  J Exp Med       Date:  1958-11-01       Impact factor: 14.307

9.  Urokinase--an activator of plasminogen from human urine. Experiences with intravenous application on twenty-two patients.

Authors:  F HANSEN; M JORGENSEN; N O KJELDGAARD; J PLOUG
Journal:  Angiology       Date:  1961-08       Impact factor: 3.619

10.  The consumption of some components involved in physiological blood coagulation.

Authors:  A S DOUGLAS; R BIGGS
Journal:  Glasgow Med J       Date:  1953-08
View more
  21 in total

Review 1.  THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors:  J L STAFFORD
Journal:  J Clin Pathol       Date:  1964-09       Impact factor: 3.411

2.  THROMBOLYTIC THERAPY.

Authors:  A S DOUGLAS; G P MCNICOL
Journal:  Proc R Soc Med       Date:  1964-07

3.  STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT.

Authors:  G P MCNICOL; A S DOUGLAS
Journal:  Br Med J       Date:  1965-05-01

4.  CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.

Authors:  A M GORDON; G P MCNICOL; A H DUBBER; G A MCDONALD; A S DOUGLAS
Journal:  Br Med J       Date:  1965-06-26

5.  Treatment of peripheral arterial occlusion by streptokinase perfusion.

Authors:  G P MCNICOL; W REID; W H BAIN; A S DOUGLAS
Journal:  Br Med J       Date:  1963-06-08

6.  Thrombolytic therapy.

Authors:  G P MCNICOL
Journal:  Proc R Soc Med       Date:  1963-05

Review 7.  Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.

Authors:  D Ogston; A S Douglas
Journal:  Drugs       Date:  1971       Impact factor: 9.546

8.  Study of proteins and fibrinolysis in patients with glomerulonephritis.

Authors:  E N Wardle; I S Menon; S P Rastogi
Journal:  Br Med J       Date:  1970-05-02

9.  Idiopathic gangrene in African adults.

Authors:  R D Barr; A D Roy; J R Miller
Journal:  Br Med J       Date:  1972-11-04

10.  Effect of intravenous prostaglandin E 2 on platelet function, coagulation, and fibrinolysis.

Authors:  P W Howie; A A Calder; C D Forbes; C R Prentice
Journal:  J Clin Pathol       Date:  1973-05       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.